Revive Therapeutics (RVVTF) Regulatory Update Archive.
April 12th, 2022 update. Discusses potentially halting the Study early due to positive efficacy based on other clinical outcomes evaluated such as the rate...
Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in...
American Chemical Society
May 2020.
Higher rates of serious illness and death from coronavirus SARS-CoV-2 (COVID-19) infection among older people and those who have comorbidities...
Revive Therapeutics Announces Entry Into Phase III FDA Trial Using Glutathione Boosting Bucillamine.
Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial
TORONTO, April 23, 2020 (GLOBE NEWSWIRE) --Revive Therapeutics Ltd.Ltd....
Latest article
A Turnaround at Mitesco Coming? Mitesco Moves Into Mini-Data Centers.
Last Round (turnaround that is) worked great, back in 2019, Trading From $0.02 to $0.50. And no, we Didn't Sell a Single Share (waa)....
Mining Legends: Dr Sergei Diakov
Meet Dr. Sergei Diakov. Most investors have never heard his name, but global mining giants like BHP, Anglo American, and AngloGold Ashanti know exactly...
BCM Resource Corp (B.V), We’re Up 137% in one Week!
Well That's Working out Quite Well..
When we got the news the other day that Mining Legend Dr. Sergei Diakov, reported some rather excellent numbers...
